Serinus Biosciences

Hitting multiple cancers with a single therapeutic
Location
Year Founded
2022
Company Size
1 - 5 People
Hiring
Funding Raised
Not Specified
About Serinus Biosciences
Serinus Bio is redefining precision in cancer therapeutics. Founded by MIT PhDs and supported by top investors, Serinus Bio is targeting the most pressing problem of cancer therapeutics – clinical translation. We design technology to determine how molecules function inside each tumor cell. By leveraging knowledge-primed models and cutting-edge cancer biology we are creating a new generation of AI for drug discovery. Our technology enables the development of drugs that work across a wide range of patient populations, override resistance mechanisms, and enable combinations by design.
Profile ID: #331460
Latest Jobs
Founders & Leadership
Financials Beta
Business Model: Not Specified
Revenues: Not Specified
Expenses: Not Specified
Debt: Request
Operating Status: Active
Funding Raised: $0
Investment Rounds: 0 Rounds
Funding Stage: Not Specified
Last Funding Date: Not Specified